Scientists Map How Chemicals Block Male Development, Creating New Test for Endocrine Disruptors
Researchers have created a detailed molecular roadmap showing how anti-androgenic chemicals disrupt male sexual development in mammals — a finding that could transform how regulators screen thousands of industrial chemicals for hormone-disrupting effects. The work provides a scientific foundation for faster, cheaper testing methods that replace traditional animal studies.
Originaltitel: AOP report: Adverse Outcome Pathway Network for Developmental Androgen Signalling-Inhibition Leading to increased Nipple/Areola Retention in Male Offspring
In murine species such as laboratory mice and rats, the number of nipples is a sexually dimorphic trait, with males typically not expressing nipples. This is an androgen-sensitive trait, with regression of the nipple anlagen dictated by high androgen levels during development. Nipple/areola retention (NR) in male rodents is thus considered a sensitive marker of disrupted androgen signalling during development and used to identify chemicals with anti-androgenic effects. Here, we have developed an Adverse Outcome Pathway Network (AOPN) for NR induced by reduced androgen signalling during critical developmental life stages. The network integrates three AOPs covering: i) inhibited testosterone production, ii) reduced conversion to DHT, and iii) direct AR antagonism. It supports the regulatory application of NR as a measure of endocrine disruption relevant for human health and the use of NR as an indicator of anti-androgenicity in mammals and other vertebrates in the environment. It presents key events (KEs) and Key Event Relationships (KERs) that can be leveraged to enhance the use of new approach methodologies, enhancing predictive toxicology and assessment of endocrine disruptors.